Most investors think stocks under $10 are junk. Meanwhile, institutional analysts are quietly slapping "Strong Buy" ratings on three specific companies trading around $5.
These aren't pump-and-dumps. They are real businesses with massive revenue figures:
The Fintech: Handling $270M+ quarterly revenue across 190 countries.
The Biotech: Flagship product posted 92% YoY sales growth.
The Super-App: Generated $873M in revenue in Q3 alone.
By clicking this link you agree to receive emails from us and our affiliates. You can opt out at any time. - Privacy Policy
HEALTH & WELLNESS
One in Six Medicare Beneficiaries Use Telehealth for Essential Care
1. In this cross-sectional study, 16.4% of Medicare beneficiaries had at least one telehealth visit between 2021 and 2023, with users more likely to h...
Amid chop, we’re seeing early momentum in select small-caps. Our free note explains the thesis, names the tickers, and shows how to monitor the setups live.
This new blood test could detect cancer before it shows up on scans
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detecti...
How Trump saved TikTok: Backstory of a 2-year campaign
President Trump had just won reelection and was basking in the parade of congratulatory pilgrimages to Mar-a-Lago. On this day in November 2024, an ol...
